Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:JNS

Janus Capital Group (JNS) Stock Price, News & Analysis

Janus Capital Group logo

About Janus Capital Group Stock (NYSE:JNS)

Advanced Chart

Key Stats

Today's Range
$14.17
$14.17
50-Day Range
N/A
52-Week Range
$11.95
$16.62
Volume
N/A
Average Volume
2.45 million shs
Market Capitalization
N/A
P/E Ratio
8.34
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive JNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Janus Capital Group and its competitors with MarketBeat's FREE daily newsletter.

JNS Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Janus Henderson European Focus I
See More Headlines

JNS Stock Analysis - Frequently Asked Questions

Janus Capital Group Inc (NYSE:JNS) issued its quarterly earnings data on Tuesday, July, 26th. The asset manager reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by $0.01. The company's revenue was down 7.4% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Janus Capital Group investors own include Janus Henderson Group (JHG), BlackRock (BLK), Intel (INTC), Bristol Myers Squibb (BMY), Medical Properties Trust (MPW), Banco Santander (SAN) and Crown Castle (CCI).

Company Calendar

Last Earnings
7/26/2016
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
Asset Management & Custody Banks
Current Symbol
NYSE:JNS
CIK
1065865
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
8.34
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:JNS) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners